ADP-ribosylation from molecular mechanisms to therapeutic implications.
dc.contributor.author | Suskiewicz, MJ | |
dc.contributor.author | Prokhorova, E | |
dc.contributor.author | Rack, JGM | |
dc.contributor.author | Ahel, I | |
dc.date.accessioned | 2024-07-18T10:52:02Z | |
dc.date.issued | 2023-10-12 | |
dc.date.updated | 2024-07-17T09:52:00Z | |
dc.description.abstract | ADP-ribosylation is a ubiquitous modification of biomolecules, including proteins and nucleic acids, that regulates various cellular functions in all kingdoms of life. The recent emergence of new technologies to study ADP-ribosylation has reshaped our understanding of the molecular mechanisms that govern the establishment, removal, and recognition of this modification, as well as its impact on cellular and organismal function. These advances have also revealed the intricate involvement of ADP-ribosylation in human physiology and pathology and the enormous potential that their manipulation holds for therapy. In this review, we present the state-of-the-art findings covering the work in structural biology, biochemistry, cell biology, and clinical aspects of ADP-ribosylation. | en_GB |
dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
dc.description.sponsorship | Wellcome Trust | en_GB |
dc.description.sponsorship | Wellcome Trust | en_GB |
dc.description.sponsorship | Oxford University Challenge Seed Fund | en_GB |
dc.description.sponsorship | Biotechnology and Biological Sciences Research Council (BBSRC) | en_GB |
dc.description.sponsorship | Ovarian Cancer Research Alliance | en_GB |
dc.description.sponsorship | European Research Council | en_GB |
dc.description.sponsorship | Ligue contre le Cancer | en_GB |
dc.description.sponsorship | French National Centre for Scientific Research (CNRS) | en_GB |
dc.description.sponsorship | National Institute for Health Research | en_GB |
dc.format.extent | 4475-4495 | |
dc.format.medium | ||
dc.identifier.citation | Vol. 186, No. 21, pp. 4475-4495 | en_GB |
dc.identifier.doi | https://doi.org/10.1016/j.cell.2023.08.030 | |
dc.identifier.grantnumber | MR/N006364/2 | en_GB |
dc.identifier.grantnumber | MR/V033417/1 | en_GB |
dc.identifier.grantnumber | 210634 | en_GB |
dc.identifier.grantnumber | 223107 | en_GB |
dc.identifier.grantnumber | USCF 456 | en_GB |
dc.identifier.grantnumber | BB/R007195/1 | en_GB |
dc.identifier.grantnumber | 813369 | en_GB |
dc.identifier.grantnumber | 101078837 | en_GB |
dc.identifier.grantnumber | CSIRGO 2022 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/136759 | |
dc.identifier | ORCID: 0000-0001-8341-6439 (Rack, Johannes GM) | |
dc.identifier | ScopusID: 56715439800 (Rack, Johannes GM) | |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/37832523 | en_GB |
dc.rights | © 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | en_GB |
dc.title | ADP-ribosylation from molecular mechanisms to therapeutic implications. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2024-07-18T10:52:02Z | |
dc.identifier.issn | 0092-8674 | |
exeter.place-of-publication | United States | |
dc.description | This is the final version. Available from Elsevier via the DOI in this record. | en_GB |
dc.identifier.eissn | 1097-4172 | |
dc.identifier.journal | Cell | en_GB |
dc.relation.ispartof | Cell, 186(21) | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2023-08-23 | |
dc.rights.license | CC BY | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2023-10-12 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2024-07-18T10:42:28Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2024-07-18T10:52:09Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2023-10-12 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2023 The Author(s). Published by Elsevier Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).